These studies also present GLUT1 as an overall metabolic marker for the pancreatic cancer cells, whereas, IDH3A may serve as an overall marker for the lung metastatic lesions of pancreatic adenocarcinoma. This evidence concerns the gene SLC2A1 and pancreatic adenocarcinoma.